Dominika Chalupská

1.7k total citations
35 papers, 1.2k citations indexed

About

Dominika Chalupská is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Dominika Chalupská has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Infectious Diseases and 7 papers in Cell Biology. Recurrent topics in Dominika Chalupská's work include RNA and protein synthesis mechanisms (7 papers), Cellular transport and secretion (6 papers) and interferon and immune responses (5 papers). Dominika Chalupská is often cited by papers focused on RNA and protein synthesis mechanisms (7 papers), Cellular transport and secretion (6 papers) and interferon and immune responses (5 papers). Dominika Chalupská collaborates with scholars based in Czechia, United States and Poland. Dominika Chalupská's co-authors include Evžen Bouřa, Radim Nencka, Václav Veverka, Martin Klíma, Piotr Górnicki, Robert Haselkorn, Jan Šilhán, Jana Humpolíčková, Dhurvas Chandrasekaran Dinesh and Tamás Balla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Dominika Chalupská

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by Dominika Chalupská

Since Specialization

Citations

This map shows the geographic impact of Dominika Chalupská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominika Chalupská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominika Chalupská more than expected).

Fields of papers citing papers by Dominika Chalupská

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominika Chalupská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominika Chalupská. The network helps show where Dominika Chalupská may publish in the future.

Co-authorship network of co-authors of Dominika Chalupská

This figure shows the co-authorship network connecting the top 25 collaborators of Dominika Chalupská. A scholar is included among the top collaborators of Dominika Chalupská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominika Chalupská. Dominika Chalupská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides 2024 ·RSC Medicinal Chemistry ·(unknown), Dominika Chalupská, Milan Dejmek, (unknown), (unknown), Michal Šála, Karel Chalupský, Petra Krafčíková, (unknown), (unknown), Eliška Procházková, Blanka Klepetářová, (unknown), (unknown), Helena Mertlíková‐Kaiserová, Evžen Bouřa, Jan Weber, Radim Nencka	5
2	Structural and functional insights in flavivirus NS5 proteins gained by the structure of Ntaya virus polymerase and methyltransferase 2024 ·Structure ·(unknown), Petra Krafčíková, Martin Klíma, Dominika Chalupská, Karel Chalupský, (unknown), Evžen Bouřa	3
3	Subunit-Dependent Surface Mobility and Localization of NMDA Receptors in Hippocampal Neurons Measured Using Nanobody Probes 2023 ·Journal of Neuroscience ·(unknown), (unknown), Martin Klíma, (unknown), Marek Ladislav, (unknown), (unknown), (unknown), (unknown), (unknown), Jana Humpolíčková, Dominika Chalupská, Jan Šilhán, Martina Kaniaková, Barbora Hrčka Krausová, Evžen Bouřa, Martin Zapotocky, Martin Hořák	3
4	Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors 2023 ·ACS Omega ·(unknown), Dominika Chalupská, Karel Chalupský, (unknown), (unknown), Petra Krafčíková, (unknown), Michal Šála, Milan Dejmek, (unknown), (unknown), Jaroslav Kozák, (unknown), Masoud Vedadi, Jan Weber, Helena Mertlíková‐Kaiserová, Radim Nencka	13
5	Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase 2023 ·Nature Communications ·Jan Šilhán, Martin Klíma, (unknown), (unknown), Dominika Chalupská, Karel Chalupský, (unknown), Radim Nencka, Evžen Bouřa	29
6	Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Kamil Hercík, (unknown), Dominika Chalupská, Milan Dejmek, Michal Šála, Miroslav Hájek, Evžen Bouřa, Helena Mertlíková‐Kaiserová, Radim Nencka	1
7	Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Martin Klíma, (unknown), Dominika Chalupská, Milan Dejmek, Michal Šála, Helena Mertlíková‐Kaiserová, Evžen Bouřa, Radim Nencka	5
8	The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors 2022 ·Neuropharmacology ·(unknown), Marek Ladislav, (unknown), (unknown), (unknown), Barbora Hrčka Krausová, (unknown), (unknown), (unknown), Martin Klíma, Dominika Chalupská, Martin Hořák	9
9	Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit 2021 ·Viruses ·(unknown), (unknown), Jan Hodek, Karel Chalupský, Petra Krafčíková, Dominika Chalupská, (unknown), Jan Weber, Evžen Bouřa, Martin Klíma	11
10	Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein 2020 ·PLoS Pathogens ·Dhurvas Chandrasekaran Dinesh, Dominika Chalupská, Jan Šilhán, (unknown), Radim Nencka, Václav Veverka, Evžen Bouřa	189
11	Phosphatidylinositol 4-kinase IIIβ (PI4KB) forms highly flexible heterocomplexes that include ACBD3, 14-3-3, and Rab11 proteins 2019 ·Scientific Reports ·Dominika Chalupská, Bartosz Różycki, Jana Humpolíčková, Lenka Faltova, Martin Klíma, Evžen Bouřa	20
12	Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites 2019 ·PLoS Pathogens ·(unknown), Heyrhyoung Lyoo, Bartosz Różycki, Dominika Chalupská, (unknown), Jana Humpolíčková, Jeroen R. P. M. Strating, Frank J. M. van Kuppeveld, Evžen Bouřa, Martin Klíma	22
13	A large scale high-throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha 2019 ·Journal of Lipid Research ·Nivedita Sengupta, Marko Jović, Elena Barnaeva, David W. Kim, Xin Hu, Noel Southall, Milan Dejmek, (unknown), Radim Nencka, (unknown), Dominika Chalupská, Evžen Bouřa, Marc Ferrer, Juan Marugán, Tamás Balla	16
14	PI(4,5)P2 controls plasma membrane PI4P and PS levels via ORP5/8 recruitment to ER–PM contact sites 2018 ·The Journal of Cell Biology ·Mira Sohn, Marek Korzeniowski, James P. Zewe, Rachel C. Wills, Gerald Hammond, Jana Humpolíčková, Lukáš Vrzal, Dominika Chalupská, Václav Veverka, Gregory D. Fairn, Evžen Bouřa, Tamás Balla	139
15	Kobuviral Non-structural 3A Proteins Act as Molecular Harnesses to Hijack the Host ACBD3 Protein 2017 ·Structure ·Martin Klíma, Dominika Chalupská, Bartosz Różycki, Jana Humpolíčková, Lenka Řežábková, Jan Šilhán, (unknown), Anna Dubánková, Evžen Bouřa	36
16	Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein 2016 ·Scientific Reports ·Martin Klíma, Dániel J. Tóth, R. Hexnerova, (unknown), Dominika Chalupská, Jan Tykvart, Lenka Řežábková, Nivedita Sengupta, Petr Man, Anna Dubánková, Jana Humpolíčková, Radim Nencka, Václav Veverka, Tamás Balla, Evžen Bouřa	69
17	The high-resolution crystal structure of phosphatidylinositol 4-kinase IIβ and the crystal structure of phosphatidylinositol 4-kinase IIα containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design 2015 ·Acta Crystallographica Section D Biological Crystallography ·Martin Klíma, (unknown), Dominika Chalupská, Hubert Hřebabecký, Milan Dejmek, Radim Nencka, Evžen Bouřa	22
18	The crystal structure of the phosphatidylinositol 4‐kinase II α 2014 ·EMBO Reports ·(unknown), Dominika Chalupská, Bartosz Różycki, Marko Jović, Éva Wisniewski, Martin Klíma, Anna Dubánková, Daniel P. Kloer, Radim Nencka, Tamás Balla, Evžen Bouřa	49
19	Norbornane-based nucleoside and nucleotide analogues locked in North conformation 2014 ·Bioorganic & Medicinal Chemistry ·Milan Dejmek, Michal Šála, Hubert Hřebabecký, Martin Dračínský, Eliška Procházková, Dominika Chalupská, Martin Klíma, (unknown), Miroslav Hájek, Graciela Andreï, Lieve Naesens, Pieter Leyssen, Johan Neyts, Jan Balzarini, Evžen Bouřa, Radim Nencka	17
20	Adaptation of an L-Proline Adenylation Domain to Use 4-Propyl-L-Proline in the Evolution of Lincosamide Biosynthesis 2013 ·PLoS ONE ·(unknown), Tomáš Kučera, Dominika Chalupská, Radek Gažák, (unknown), Dana Ulanová, Jan Kopecký, Eva Kutějová, Lucie Najmanová, Jiřı́ Janata	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact